64
Participants
Start Date
November 16, 2021
Primary Completion Date
November 16, 2023
Study Completion Date
March 7, 2028
Lu AF82422
Solution for infusion
Placebo
Solution for infusion
NYU Langone Health Medical Center, New York
Columbia University Medical Center - The Neurological Institute of New York, New York
University Of Pittsburgh, Pittsburgh
Penn State Milton S. Hershey Medical Center - Penn State Hershey Neuroscience Institute (PSHNI), Hershey
University of Pennsylvania, Philadelphia
University of Florida Norman Fixel Institute for Neurological Diseases, Gainesville
Parkinson's Disease And Movement Disorder Center Of Boca Raton, Boca Raton
Mayo Clinic, Rochester
Endeavor Health - Glenbrook Hospital, Glenview
Rush University Medical Center, Rush University Cancer Center, Chicago
CenExel Rocky Mountain Clinical Research, LLC, Englewood
University of California - San Diego, La Jolla
The Parkinsons and Movement Disorder Institute, Fountain Valley
University of California, San Francisco Neurosciences Clinical Research Unit, San Francisco
Beth Israel Deaconess Medical Center, Boston
University Nebraska Medical Center, Omaha
Fujita Health University Hospital, Toyoake
Gifu University Hospital, Gifu
National Hospital Organization Sendai Nishitaga Hospital, Sendai
H. Lundbeck A/S
INDUSTRY